scispace - formally typeset
C

Christopher M. Rembold

Researcher at University of Virginia

Publications -  103
Citations -  4846

Christopher M. Rembold is an academic researcher from University of Virginia. The author has contributed to research in topics: Myosin & Phosphorylation. The author has an hindex of 37, co-authored 103 publications receiving 4584 citations. Previous affiliations of Christopher M. Rembold include Mayo Clinic & University of Virginia Health System.

Papers
More filters
Journal ArticleDOI

Common Carotid Intima-Media Thickness Measurements in Cardiovascular Risk Prediction A Meta-analysis

TL;DR: The addition of common CIMT measurements to the Framingham Risk Score was associated with small improvement in 10-year risk prediction of first-time myocardial infarction or stroke, but this improvement is unlikely to be of clinical importance.
Journal ArticleDOI

Number needed to screen: development of a statistic for disease screening

TL;DR: Of the screening strategies evaluated, screening for, and treatment of, dyslipidaemia and hypertension seem to produce the largest clinical benefit.
Journal ArticleDOI

Growth of the human heart relative to body surface area.

TL;DR: This study indicates that intracardiac areas may be indexed for body surface area, but that linear dimensions and volumes have a nonlinear relation to surface area and are more appropriately indexed by surface area to the 0.5 and 1.5 power level.
Journal ArticleDOI

Myoplasmic [Ca2+] determines myosin phosphorylation in agonist-stimulated swine arterial smooth muscle.

TL;DR: The relation between phosphorylation and Vo or steady-state stress was invariant with all tested stimuli, suggesting that Ca2+-dependent crossbridge phosphorylated is the primary determinant of the mechanical response.
Journal ArticleDOI

Regulation of contraction and relaxation in arterial smooth muscle

TL;DR: There are two proposed mechanisms for changes in the [Ca2+]i sensitivity of phosphorylation: Ca(2+)-dependent decreases in the [*Ca2-i]i sensitive to myosin light chain kinase by Ca( 2+)-calmodulin protein kinase II and agonist-dependent increases in the[Ca2+) sensitivity ofosphorylation by inhibition of a myosIn light chain phosphatase.